在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

E6 Antibody, Biotin conjugated

Rare Species
  • 中文名稱:
    E6兔多克隆抗體, Biotin偶聯(lián)
  • 貨號(hào):
    CSB-PA365854LD01HML
  • 規(guī)格:
    ¥880
  • 其他:

產(chǎn)品詳情

  • 產(chǎn)品名稱:
    Rabbit anti-Human papillomavirus type 16 E6 Polyclonal antibody
  • Uniprot No.:
  • 基因名:
  • 別名:
    E6 antibody; Protein E6 antibody
  • 宿主:
    Rabbit
  • 反應(yīng)種屬:
    Human papillomavirus type 16
  • 免疫原:
    Recombinant Human papillomavirus type 16 Protein E6 protein (1-158AA)
  • 免疫原種屬:
    Human papillomavirus type 16
  • 標(biāo)記方式:
    Biotin
  • 克隆類型:
    Polyclonal
  • 抗體亞型:
    IgG
  • 純化方式:
    >95%, Protein G purified
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液:
    Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
  • 產(chǎn)品提供形式:
    Liquid
  • 應(yīng)用范圍:
    ELISA
  • Protocols:
  • 儲(chǔ)存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

  • 功能:
    Plays a major role in the induction and maintenance of cellular transformation. Acts mainly as an oncoprotein by stimulating the destruction of many host cell key regulatory proteins. E6 associates with host UBE3A/E6-AP ubiquitin-protein ligase, and inactivates tumor suppressors TP53 and TP73 by targeting them to the 26S proteasome for degradation. In turn, DNA damage and chromosomal instabilities increase and lead to cell proliferation and cancer development. The complex E6/E6AP targets several other substrates to degradation via the proteasome including host DLG1 or NFX1, a repressor of human telomerase reverse transcriptase (hTERT). The resulting increased expression of hTERT prevents the shortening of telomere length leading to cell immortalization. Other cellular targets including BAK1, Fas-associated death domain-containing protein (FADD) and procaspase 8, are degraded by E6/E6AP causing inhibition of apoptosis. E6 also inhibits immune response by interacting with host IRF3 and TYK2. These interactions prevent IRF3 transcriptional activities and inhibit TYK2-mediated JAK-STAT activation by interferon alpha resulting in inhibition of the interferon signaling pathway.
  • 基因功能參考文獻(xiàn):
    1. USP15 could increase the level of HPV16 E6 by inhibiting E6 degradation. PMID: 29895155
    2. Up-regulation of miR-20a by HPV16 E6 exerted growth-promoting effects by targeting PDCD6 in cervical carcinoma cells. PMID: 29710555
    3. The HPV16-E6 oncoprotein induces EMT in transgenic mice cataracts. The molecular mechanism may involve TGF-beta and Wnt/beta-catenin pathways, suggesting that the K14E6 transgenic mouse could be a useful model for the study or treatment of EMT-induced cataracts. PMID: 29888254
    4. This study provides links between the DNA damage response, the regulation of E6 human papillomavirus type 16 PDZ binding motif function, and the inhibition of p53 activity and begins to explain how virus-infected cells remain within the cell cycle, despite activation of DNA damage response pathways during productive virus infections. PMID: 29848585
    5. E6 oncogene alters host gene expression in the cervical stroma. PMID: 29073104
    6. the K14E6 versus K14E6Delta146-151 transcriptional profile provides a source of valuable data to uncover novel E6 functions in the skin. PMID: 29130045
    7. HPV16 E6 T178G mutation increases the disease risk of cervical intraepithelial neoplasia 2 and 3 PMID: 29787003
    8. the network of transcriptional interactions in HPV16-infected basal-type cervical epithelium is regulated in a concentration-dependent manner by E6/E7, via a limited number of central master-regulators. PMID: 27457222
    9. E6 association with cellular PDZ proteins promotes the nuclear localization of YAP1. PMID: 29346075
    10. Results showed that increased expression of HPV16 E6 expression level was strongly associated with malignant transformation of the cervical epithelium and the histological progression of cervical squamous cell carcinoma. PMID: 29470526
    11. human papillomavirus 16 E6, E7 genes and Long Control Region are expressed in cervical samples from Uruguayan women PMID: 29454092
    12. HPV16 E6 oncoprotein promoted the bioactivities of non-small cell lung cancer (NSCLC) cells. TLR3-Src signaling pathway might be involved in this procession by up-regulation of cytokine production. The interaction between HPV16 E6 protein and TLR3 might contribute to the poor prognosis of NSCLC. PMID: 28480962
    13. HPV16 E6-E7 promotes cancer stem-like cells phenotype in esophageal squamous cell carcinoma cells through the activation of PI3K/Akt signaling pathway PMID: 27489353
    14. Studied role of HPV16 E6 and COX-2 in invasive ductal breast cancer using qPCR and IHC, and in vitro studies. Found HPV16 E6 promoted breast cancer proliferation; Cox-2 inhibition suppressed HPV16 E6 effects on proliferation thru NF-kappaB signaling pathway. PMID: 29250535
    15. Findings indicate O-linked N-acetylglucosamine transferase (OGT) as a cellular factor involved in human papillomaviruses type 16/18 E6 and E7 expressions and cervical cancer tumorigenesis, suggesting that targeting OGT in cervical cancer may have potential therapeutic benefit. PMID: 27331873
    16. IFN-beta treatment leads to p53-indipendent apoptosis in K16 cells whereas induces senescence in K16 cells if E6 is silenced and p53 expression is restored. The levels of selected miRNAs, deregulated in K16 and K38 cells, can be modulated by IFN-beta when E6 and E7 proteins of HPV-16, but not HPV-38, are expressed. PMID: 26748726
    17. A decrease in miR-184 level by E6 oncoprotein may predict unfavorable response to cisplatin-based chemotherapy in HPV-infected non-small cell lung carcinoma patients via increasing Bcl-2 expression. PMID: 27083050
    18. Seminal studies over the last two decades have identified the transcriptional, epigenetic, and post-transcriptional roles high-risk E6 and E7 have in TERT regulation. (Review) PMID: 27863966
    19. Ablation of E6 by siRNA induces the tumor suppressor p53 and diminishes beta-defensin-3 (hBD3) in HPV-16 positive CaSki cervical cancer cells and UM-SCC-104 head and neck cancer cells. PMID: 27034006
    20. This study identifies NFX1-123 as a critical host protein partner through which 16E6 is able to subvert the immune response and in turn permit a long-lived high-risk Human papillomavirus infection. PMID: 29117186
    21. HPV E6 is capable of overriding this regulation and can promote degradation of p53 and Dlg regardless of the phosphorylation status of E6AP. PMID: 28835500
    22. Studies indicate the accuracy of HPV16 antibodies to the oncoproteins E6. PMID: 28316084
    23. Lactate and glucose production were enhanced in E6-transduced keratinocytes, likely due to raised levels of metabolic enzymes, but independent of(HIF-1alpha activity. PMID: 28857035
    24. These data highlight the importance of the carboxy-terminal motif of the E6 protein and downregulation of PAR3 in tumorigenic transformation of human cervical keratinocytes. PMID: 28440909
    25. Study presented a combined molecular dynamics/infrared spectroscopy approach to the study of ligand binding (11-residue peptide derived from the C terminus of HPV16 E6) by the PDZ1 domain of MAGI1, focusing in particular on the far-infrared region of the spectrum. PMID: 28636914
    26. HPV16 E6/E7 oncogene expression in primary human epithelial cells alters miR expression in extracellular vesicles. PMID: 28500882
    27. In three warty or basaloid SCSC HPV16-DNA and E6*I-mRNA were detected. LCM-PCR confirmed HPV16 was in p16(INK4a)-positive malignant cells. However, of three usual-type SCSC, all were HPV-negative and two expressed p53 protein but not p16(INK4a). PMID: 28376081
    28. HPV-16 E6 was confirmed to regulate microRNA miR-23b indirectly through the DNA methylation of host gene C9orf3 and thus induce c-MET and inhibit apoptosis in cervical cancer cells. PMID: 28077801
    29. Our results indicate that HPV16 E6/E7 indirectly upregulated the expression of VEGF by inhibition of liver kinase B1 expression and upregulation of hypoxia-inducible factor 2alpha expression,thus propose a human papillomavirus-liver kinase B1-hypoxia-inducible factor 2A-vascular endothelial growth factor axis for the tumorigenesis of lung cancer PMID: 28720067
    30. HPV E6/E7 increased expression of DROSHA and DICER mRNA and protein in cervical carcinoma cells. PMID: 28448850
    31. Data show that p63 transcription factors modulate cell migration via Src-focal adhesion kinase (FAK) signaling in foreskin keratinocytes (HFK) expressing human papilloma virus (HPV)16 E6/E7 genes. PMID: 26001294
    32. Overall, this study supports the model that perturbation of cellular miR expression by human papillomavirus type 16 E6/E7 importantly contributes to the rewiring of cellular regulatory circuits that contributes to oncogenic transformation. PMID: 28049151
    33. Thus, Brd4 activates human papillomavirus 16 transcription at this integration site, and strong selection for E6/E7 expression can drive the formation of a super-enhancer-like element to promote oncogenesis. PMID: 27624132
    34. Collectively, these results indicate that human papillomavirus 16 E6 induces upregulation of APOBEC3B through increased levels of TEADs, highlighting the importance of the TEAD-APOBEC3B axis in carcinogenesis. PMID: 28077648
    35. A transcriptomic landscape of human papillomavirus 16 E6-regulated gene expression and splicing events in cervical cancer patients has been presented. PMID: 27859058
    36. The ubiquitylation of beta-catenin by E6AP was dependent on its E3 ubiquitin ligase activity, but it was proteasome-independent and did not require HPV16-E6. PMID: 27902311
    37. nucleotide changes in E6 occur significantly more often in the mixed form of viral DNA and in low-grade squamous intraepithelial lesions; and the variants without additional mutations may promote integration of HPV16 genome. PMID: 27801430
    38. We also found VPA suppressed oncogene E6 in a Notch-independent manner, and induced significant apoptosis in E6-overexpressing HPV positive CaSki cells. PMID: 27176495
    39. Data show that alpha-linolenic acid (ALA) decreased the expression of VEGF and COX2 proteins, and reduced the expression of Human papillomavirus type 16/18 onco-proteins E6 and E7, resulting into restoration of expression of tumor suppressor proteins, p53 and Rb in cervical cancer cell lines. PMID: 26440049
    40. Expression changes of E6 and E7 significantly promoted the protein expression of HIF-1alpha, the expression of both protein and mRNA of GLUT1, but had no effect on the expression of HIF-1alpha mRNA in lung cancer cells. PMID: 26508030
    41. our results suggest that ERK1/2 signaling pathway is involved in HPV-16 E6 but not E7 oncoprotein-induced HIF-1a, VEGF, and IL-8 expression in NSCLC cells, leading to the enhanced angiogenesis in vitro. PMID: 26931433
    42. Our data suggest that the use of HPV 16 spliced transcripts may help to predict for poorer outcomes in patients with HPV positive oropharyngeal cancer PMID: 26575468
    43. Within the limitations of this study, the immunoexpression of HPV 16/18 E6 and E7 oncoproteins may have prognostic value regarding cervical squamous intraepithelial lesions persistence in HIV-positive women. PMID: 26909984
    44. HPV16 E6/E7 Oncoproteins Alter the In Vitro Growth of CD44+NGFR+ Human Tonsillar Epithelial Cells. PMID: 26527383
    45. Human papillomavirus type 16 E6 protein, a major etiological molecule of cervical cancer, maintains high YAP protein levels in cervical cancer cells by preventing proteasome-dependent YAP degradation to drive cervical cancer cell proliferation. PMID: 26417066
    46. E6 and E7 have roles in methylation of tumor suppressor genes and inducing phenotype transformation of human cervical carcinoma cells PMID: 26329329
    47. Here we demonstrate that E7, and to a lesser extend E6, strongly reduce NFkappaB activation in response to the inflammatory mediator imiquimod. Moreover, we establish that undifferentiated keratinocytes do not express the putative receptor for imiquimod, TLR7 PMID: 26268216
    48. The data indicate for the first time that increased cytoplasmic human papillomavirus type 16 E6 levels associated with malignant progression alter Cx43 trafficking and recycling to the membrane and the E6/human Dlg interaction may be involved. PMID: 26445057
    49. High-risk HPV-type lesions might inhibit the chemokine CCL20 on Langerhans cells through E6 and E7 to escape the immune response. PMID: 26400278
    50. E6 protein functioning as a host miRna modulator and play a role of HPV induced carcinogenesis in patient diagnosed with cervical cancer. PMID: 26384051

    顯示更多

    收起更多

  • 亞細(xì)胞定位:
    Host cytoplasm. Host nucleus.
  • 蛋白家族:
    Papillomaviridae E6 protein family
  • 數(shù)據(jù)庫鏈接:

    KEGG: vg:1489078



主站蜘蛛池模板: 亚洲一区二区三区偷拍女厕| 久久国产免费观看精品a片| 国产激情高中生呻吟视频| 欧美做爰性生交视频| 免费的很黄很污的视频| 青青草国产免费久久久| 国产精品高潮呻吟av久久男男| 亚洲国产成人久久综合区| 国产啪精品视频网站| 欧美大屁股xxxxhd黑色| 乱码视频午夜间在线观看| 在教室伦流澡到高潮h麻豆| 国产xxxx视频在线观看| 欧美大屁股xxxxhd黑色| 高清性欧美暴力猛交| 18禁美女裸体无遮挡免费观看国产 | 亚洲国产精品久久久久网站| 蜜臀国产在线视频| 学生妹亚洲一区二区| 无修无码h里番在线播放网站| 人狥杂交一区欧美二区| 人妻人人做人碰人人添| 国产精品久久久久久影视| 国产午夜片无码区在线观看爱情网| 精品国产在天天在线观看| 国产国产乱老熟女视频网站97| 国产无遮挡无码视频免费软件| 在线毛片片免费观看| 欧美两根一起进3p在线观看| 亚洲色婷婷久久精品av蜜桃久久| 熟妇人妻无码中文字幕老熟妇| 卡1卡2卡3精品接入口| 国产成人青青久久大片| 亚洲中文字幕无码中文字在线| 国产综合色产在线精品| 精品系列无码一区二区三区 | 成人亚洲国产精品一区不卡| 影音先锋女人aa鲁色资源| 四虎影视88aa久久人妻| 久久996re热这里有精品| 男女做爰猛烈叫床视频免费|